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GM-CSF is an important cytokine that regulates the proliferation of monocytes/
macrophages and its various functions during health and disease. Although growing
evidences support the notion that GM-CSF could play a major role in immunity against
tuberculosis (TB) infection, the mechanism of GM-CSF mediated protective effect against
TB remains largely unknown. Here in this study we examined the secreted levels of GMCSF by human macrophages from different donors along with the GM-CSF dependent
cellular processes that are critical for control of M. tuberculosis infection. While
macrophage of different donors varied in their ability to produce GM-CSF, a signiﬁcant
correlation was observed between secreted levels of GM-CSF, survial of macrophages
and intra-macrophage control of Mycobacterium tuberculosis bacilli. GM-CSF levels
secreted by macrophages negatively correlated with the intra-macrophage
M. tuberculosis burden, survival of infected host macrophages positively correlated with
their GM-CSF levels. GM-CSF-dependent prolonged survival of human macrophages
also correlated with signiﬁcantly decreased bacterial burden and increased expression of
self-renewal/cell-survival associated genes such as BCL-2 and HSP27. Antibodymediated depletion of GM-CSF in macrophages resulted in induction of signiﬁcantly
elevated levels of apoptotic/necrotic cell death and a simultaneous decrease in
autophagic ﬂux. Additionally, protective macrophages against M. tuberculosis that
produced more GM-CSF, induced a stronger granulomatous response and produced
signiﬁcantly increased levels of IL-1b, IL-12 and IL-10 and decreased levels of TNF-a and
IL-6. In parallel, macrophages isolated from the peripheral blood of active TB patients
exhibited reduced capacity to control the intracellular growth of M. tuberculosis and
produced signiﬁcantly lower levels of GM-CSF. Remarkably, as compared to healthy
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controls, macrophages of active TB patients exhibited signiﬁcantly altered metabolic state
correlating with their GM-CSF secretion levels. Altogether, these results suggest that
relative levels of GM-CSF produced by human macrophages plays a critical role in
preventing cell death and maintaining a protective differentiation and metabolic state of the
host cell against M. tuberculosis infection.
Keywords: macrophages, Mycobacterium tuberculosis, tuberculosis, granulocyte macrophage colony-stimulating
factor, cell death, antigen presentation, autophagy, cellular metabolism

macrophages, alveolar epithelial cells; and importance of this
growth factor in M. tuberculosis infection control has previously
been reported by us and others albeit in a mouse model of
tuberculosis which is inherently susceptible to tuberculosis (15,
16). In a more recent study we found that human macrophages
produce signiﬁcantly higher amounts of GM-CSF than mouse
macrophages, and have signiﬁcantly increased cell survival and M.
tuberculosis infection control abilities (17). This ﬁnding led us to
hypothesize that lower levels of GM-CSF may relate to TB
susceptibility in humans.
Here in this study we quantiﬁed the levels of GM-CSF
produced by primary macrophages isolated from active TB and
healthy donors and examined the ability of the cells to control M.
tuberculosis infection in vitro. The amount of GM-CSF produced
by macrophages varied signiﬁcantly between donors, but we
observed a clear correlation between the secreted levels of GMCSF and the ability of macrophages to prolong their survival and
control M. tuberculosis infection. In macrophages derived from
active TB patients, we observed lower levels of GM-CSF
production, reduced self-survival, and increased proliferation of
M. tuberculosis bacilli. We interrogated the cellular mechanisms
underlying GM-CSF-mediated TB immunity using antibodymediated GM-CSF blockade and exogenous GM-CSF
supplementation in primary human macrophages. We assessed
the effect of neutralized and enhanced GM-CSF signaling on host
macrophages survival, bacterial burden, differentiation state,
inﬂammation state, autophagy ﬂux, phagosome maturation
events, antigen processing, cytokine secretion, and metabolism.
Our ﬁndings indicate that self-survival, anti-inﬂammatory
properties, metabolic state, differentiation state, and autophagic
processes of macrophages are directly related to GM-CSFdependent intracellular restriction of M. tuberculosis. These data
emphasize the importance of macrophage produced GM-CSF in
controlling M. tuberculosis infection and deﬁne GM-CSFdependent cellular pathways that contribute to intracellular
defense mechanisms against TB.

INTRODUCTION
Tuberculosis (TB) remains a major health concern worldwide,
despite vaccine coverage efforts. With a current worldwide
incidence of approximately 10 million new TB cases and 1.3
million associated deaths annually, TB is the leading cause of
death by an infectious disease worldwide (1). TB also accounts for
approximately 40% of deaths among people with human
immunodeﬁciency virus (HIV) (2). Failure to control TB is
attributed to several factors, including treatment non-compliance
and failure, emergence of multi drug resistant (MDR) strains, poor
diagnostic tools, poor vaccine efﬁcacy of BCG, and socioeconomic
challenges (3). A vaccine that effectively protects against different
forms of TB across all age groups would dramatically reduce disease
burden worldwide. However, identifying key immune components
that protect against TB remains a major challenge in developing an
effective vaccine.
Traditionally, protective immunity to TB has been attributed to
a T-cell-mediated immune response, with CD4+ T cells playing a
critical role (4, 5). However, more recent experimental evidence
now suggests that host resistance to Mycobacterium tuberculosis
infection could be independent of IFN-g and TNF-a secretion
from CD4+ T cells (6, 7). Evidence from clinical and experimental
studies supports a more critical role of innate cells in protective
immunity against TB (8, 9). Macrophages, the primary innate cell
involved in the initial uptake of M. tuberculosis, also possess Tcell-independent, intrinsic bactericidal activity (10, 11). Further,
the relative permissiveness of macrophages for intracellular
growth of M. tuberculosis varies, supporting the relevance of
macrophage-mediated innate immunity in TB disease (12).
However, the mechanism(s) through which macrophages restrict
intra-macrophage growth of M. tuberculosis to provide protective
immunity against TB is rather unclear. Granulocyte-macrophage
colony-stimulating factor (GM-CSF) is one key component that is
now being increasingly recognized for its critical role in resistance
against TB (13–15). GM-CSF could be produced by a variety of
cells including, conventional and non-conventional T cells,
Abbreviations: TB, Tuberculosis; GM-CSF, Granulocyte Macrophage Colony
Stimulating Factor; TNF-a, Tumor Necrosis Factor alpha; IL-1b, Interluking 1
beta; IL-6, Interleukin 6; Il-10, Interleukin 10; IL-12, Interleukin 12; IL-13,
Interleukin 13; BCL-2, B Cell Lymphoma 2; HSP27, Heat Shock Protein 27;
IFN-g, Interferon gamma; HLA-DR, Human Leukocyte Antigen – DR isotype;
NO, Nitric Oxide; DM, Diabetes Mellitus; PI3K, Phosphoinositide 3-Kinase;
MEK1, Mitogen-Activated Protein Pinase 1; p38 MAPK, p38 Mitogen-Activated
Protein Kinases; Ink T cell, Invariant Natural Killer T cells; CD4, Cluster of
Differentiation 4; APC, Antigen Presenting Cells.
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METHODS
Monocytes/Macrophages From Healthy
Donors, Contacts, or TB Patients
All blood samples were collected per approved institutional
review board protocols. CD14 magnetic beads (Miltenyi Inc.,
USA) were used to purify monocytes from PBMCs that were
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plated in 6 or 24 tissue culture well plates at a density of 5x106
and 1x106 cells per well, respectively. Eight-well slide chambers
or coverslips received 104 cells per chamber for confocal/
immunoﬂuorescent imaging studies. CD14 bead puriﬁed
monocytes were grown in Iscove’s medium (IMDM) with 10%
fetal bovine serum (FBS) and 10 mg/mL penicillin and
gentamycin for 24 hours and then plated in antibiotics-free
medium until 7 days for before differentiation into macrophages.

Technologies, DAL1025) was used to assess cell viability by
adding the ready-to-use 1X solution to uninfected or M.
tuberculosis-infected macrophages at various time points,
followed by ﬂuorescence measurement through ﬂuorimeter per
the manufacturer’s protocol. A ﬂuorescence-based apoptosis/
necrosis detection kit (Abcam #ab176749) that can
simultaneously monitor apoptotic, necrotic, and healthy cells
was used to measure and quantify apoptosis and necrosis in M.
tuberculosis infected, uninfected, differentiated, and
undifferentiated macrophages using a ﬂuorescence microscope.

Human TB Patients and Healthy Contacts
PBMCs were collected from deidentiﬁed, known TB patients and
their healthy contacts under the approved IRB protocols of Dr.
Restrepo from Reynosa, Mexico, under a collaboration.
Approved IRB protocol: HSC-SPH-12-0037.

Ex Vivo M. tuberculosis Ag85B Antigen
Presentation to CD4 T Cells
We have previously described this method in detail, and the
original method described by the Harding lab has been
extensively used by us and others for in vitro antigen
presentation by macrophages (18). Brieﬂy, M. tuberculosisinfected macrophages were washed after a 4-hour infection
and overlaid with the F9A6-CD4 T cell hybridoma (gift from
Dr. David Canaday lab) that recognizes an Ag85B epitope in the
context of human HLA-DR1. IL-2 secreted from hybridoma T
cells or other cytokines secreted from M. tuberculosis-infected
macrophages were determined using a sandwich ELISA
kit (Biolegend).

Bacterial Strains, Culture Conditions, and Infection
of macrophages
Log phase organisms of wild-type M. tuberculosis H37Rv (ATCC
27294) were cultured in Middlebrook 7H9 broth for 7 days and
were then frozen in aliquots. Before use, aliquots were thawed,
washed three times in PBS (12,000 rpm; 15 mins), sonicated at 4
watts using a sonication probe and dispersed suspension
matched with McFarland #1 in turbidity (10 8 CFU/mL).
Macrophages were infected with M. tuberculosis at MOI of 1
with a 4 hour phagocytosis incubation time. Extracellular
bacteria were then removed through washing with sterile
IMDM medium thrice and macrophages were further
incubated at 37°C in a CO2 incubator.

Western Blot Analysis
Six well tissue culture plates were seeded with macrophages.
They were infected with M. tuberculosis for 4 hours at MOI of 1
and then washed three times with PBS and re-plated in the
medium. At different time points, MFs were washed three times
with 1x PBS, and 50 µL RIPA buffer containing APM (antiprotease mix) was added to each well and incubated for 15
minutes. Lysates were then collected, and protein quantiﬁcation
(Bradford assay, Pierce Coomassie Plus cat no. 23238; Thermo
Fisher Scientiﬁc) was performed. The quantitative Wes capillary
immunoassay was used for the Western blot, in which the lysates
were separated and detected using Wes separation capillary
cartridge 12-230 kDa along with Wes Anti-Rabbit Detection
Module (Simple Western system and Compass Software, Protein
Simple). In brief, glass microcapillaries were loaded with stacking
and separation matrices followed by sample loading. During
capillary electrophoresis, proteins were separated by size and
then immobilized to the capillary wall (19). Samples were loaded
at 1 mg/ml dilution and the primary rabbit antibody ATG 5 and
7 was used at a dilution of 1:50 (ATG5: cat no.2360;cell signaling
and ATG7: cat no.8558) and b-actin (Rabbit monoclonal, SigmaAldrich # SAB5600204) were used at 1:50 dilution. Data were
analyzed with the Compass software (version 2.6.7). The area
under the curve (AUC), which represents the signal intensity of
the chemiluminescent reaction was analyzed for all the
antibodies and b-actin. Values given for protein expression
were normalized to b-actin. Quantitation of protein levels
(area under each peak; arbitrary units [A.U.]) were performed
using the Compass software (version 2.6.7).

Cytokine and Cathilicidin ELISA Assays
Cell supernatants were tested for cytokines using sandwich ELISA
kits (Biolegend and R&D systems, USA) for various cytokines
(TNF-a, IL-1b, IL-4, IL-6, IL-10, IL-12, and IL-13) secreted by
GM-CSF competent and GM-CSF depleted macrophages after
infection with M. tuberculosis. For the quantiﬁcation of
Cathilicidin through ELISA (Novus Biologicals), cell lysates of
GM-CSF competent and GM-CSF depleted macrophages after
infection with M. tuberculosis were used.

M. tuberculosis Growth Assays in
Macrophages, Cell Viability Assays, and
Cell Death Assays
Macrophages were lysed with 0.05% SDS at different time points
post-M. tuberculosis infection with or without hGM-CSF
supplementation, a-hGM-CSF antibodies, or other
pharmacological agents/inhibitors. Cell culture media along with
hGM-CSF and a-hGM-CSF antibodies were replaced every
alternate day during these experiments and assays. At different
time points, lysates were plated at serial 10-fold dilutions in PBS
using 7H11 Middlebrook agar plates (Difco Laboratories, Surrey,
UK). The plates were incubated at 37°C for 3 weeks before
counting CFUs. Data were expressed as log10- CFUs per million
macrophages. Alamar Blue cell viability reagent (Life
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Evaluation of Autophagosome Puncta,
LC3B Containing Endosomes, and Their
Localization With rfp M. tuberculosis
Within Macrophages

determined using 1- or 2-way ANOVA with Tukey’s posthoc
test (GraphPad PRISM software).

GM-CSF competent and depleted macrophages were plated in 8well chamber slides at a density of 104 cells per chamber and
infected with red ﬂuorescent protein (RFP) expressing M.
tuberculosis (rfp M. tuberculosis) at an MOI of 1. Per
established procedures, autophagy was evaluated using at least
three criteria. Fixed macrophages were permeabilized and
stained using speciﬁc antibodies against LC3 followed by
secondary staining with Alexﬂuor488 (Jackson Immunoresearch
# 109-545-003) as described previously (19). Percent rfp M.
tuberculosis phagosomes colocalizing with antibodies was
conducted as described previously (20).

RESULTS
Monocyte GM-CSF Levels Correlate With
Host Cell Survival and Intracellular
M. tuberculosis Proliferation
We compared the levels of GM-CSF produced by monocytes
isolated from the peripheral blood of various healthy subjects (HS)
(n=26) and analyzed their bacterial load and survival during M.
tuberculosis infection in vitro. Prior to M. tuberculosis infection, we
allowed their differentiation into macrophages and measured GMCSF production. CD14+ classic monocytes, isolated from the
peripheral blood of different HS were differentiated via
adherence on cell culture plates. Quantiﬁable levels of GM-CSF
in cell culture supernatants were not detectable before 48 h using
the Sandwich ELISA method (Supplementary Figure S1). After
seven days of differentiation, adherent, fully differentiated
macrophages were isolated and infected with M. tuberculosis at
a low multiplicity of infection (MOI) of one. GM-CSF levels were
immediately detectable post-infection in these differentiated cells,
though they varied signiﬁcantly over time between donors
(Figure 1A). We also measured GM-CSF levels in an additional,
uninfected set of differentiated macrophages for comparison with
infected cells from the same donors set. Relative to uninfected
cells, infected cells produced signiﬁcantly more GM-CSF early
after infection (1-3 days) in most of the HS. However, GM-CSF
levels became more similar between these two groups at three days
post infection. We compared intracellular colony-forming units
(CFUs) of M. tuberculosis, macrophage viability, and GM-CSF
levels over time after infection and found that intracellular CFUs
declined in most individuals, though three individuals (11.5%)
showed an increase in intracellular M. tuberculosis burden
(Figure 1B). Similarly, M. tuberculosis-infected macrophage
viability declined slowly but remained over 80% seven days
post-infection in a majority of individuals (77%) (Figure 1C,
Supplementary Table 1). Macrophages from six individuals
(23%) lost over 20% cell viability by seven days post-infection
and exhibited accelerated cell death following infection
(Figure 1C). Increased production of GM-CSF directly
correlated with prolonged survival and improved intracellular
bacterial control of macrophages (Figures 1D, E). GM-CSF
levels and bacterial burden were inversely correlated in
macrophages (Figure 1D). On the other hand, there was a
strong positive correlation between GM-CSF levels and
macrophage viability after infection (Figure 1E) that was also
observed in uninfected cells (Supplementary Figure S2). Thus,
GM-CSF may contribute to long-term survival in macrophages
while preventing M. tuberculosis-induced cell death. To investigate
the association between macrophage GM-CSF production, cell
survival, and M. tuberculosis infection control in undifferentiated
cells, we infected CD14+ monocytes from different donors prior to
differentiation (Figures 1F, G). Undifferentiated monocytes did
not produce detectable levels of GM-CSF following infection with

Quantitative (QPCR) Analysis
Total RNA from macrophages was extracted using RNAeasy
mini kit (Qiagen, Germany). RNA concentration and purity
ratios (OD260/280, OD260/230) were measured using the
NanoDrop ND-1000 spectrophotometer (Thermo Fisher
Scientiﬁc, USA). cDNA synthesis was performed on a CFX96
Real-Time PCR System (Biorad, USA) using the 2X OneStep
qRT-PCR Mastermix Kit (Applied Biosystems, USA) according
to manufacturer’s instruction. Quantitative PCR (qPCR) was
performed using SYBR green probe and gene speciﬁc primers
(Supplementary Table S2). Threshold cycle numbers were
transformed to DDCt values, and the results were expressed
relative to the reference gene, GAPDH. Gene expression data
was performed using GraphPad Prism ver. 6.0 suite (GraphPad
Software). Student’s t-test was used for mean comparison
between GM-CSF competent and depleted macrophages.
Signiﬁcance was set at the 0.05 level.

Nitric Oxide (NO) and Reactive Oxygen
Specice (ROS) Estimation
Macrophages were plated in 96-well plates at a density of 1x104
cells per well in triplicate and infected with M. tuberculosis
(MOI=1). Cells were then treated with ﬂuorescent probes for
the quantiﬁcation of NO using diaminoﬂuorescein diacetate (DAF2 DA), per manufacturer’s instructions (Enzo Life Sciences, USA);
DCFDA was used to detect ROS. Quantiﬁcation of NO/ROS release
was determined by calculating the ﬂuorescence emitted over time
using an ex485 nm/em515 nm and plotting AFUs (± SD) against time
using Ascent ﬂuoroscan software version 2.6.

Statistical Analysis
All experiments were performed at least 3 times containing
triplicate wells per experimental group or combination.
Statistical parameters including the deﬁnition of central value
and spread (mean ± SD) of macrophages per group are
annotated in the corresponding ﬁgure legends. Statistical
analysis was performed with GraphPad Prism version by using,
unless otherwise stated, unpaired t tests with 95% conﬁdence
intervals. P values for CFU count in macrophages were
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FIGURE 1 | Association between GM-CSF secretion levels, bacterial burden, and cell viability of macrophages post-M. tuberculosis infection. (A) Secreted levels
of GM-CSF by M. tuberculosis in infected and uninfected macrophages of different individuals after differentiation.pg = picogram. (B) M. tuberculosis burden in
macrophages of different individuals after differentiation as measured by CFU assay over seven days of infection. (C) Cell viability of M. tuberculosis-infected
macrophages after differentiation measured by alamarBlue assay over seven days of infection. (D) Two-tailed correlation analysis between secreted GM-CSF levels
and M. tuberculosis burden in macrophages on day 7 post-infection. (E) Two-tailed correlation analysis between secreted GM-CSF levels and cell viability of
macrophages on day 7 post-infection. (F) M. tuberculosis burden in undifferentiated macrophages by CFU assay over 7 days of infection. (G) Cell viability of M.
tuberculosis-infected undifferentiated macrophages by alamarBlue assay over seven days of infection. Data represent average of three independent experiments
carried out in duplicate. Bars and error bars represent mean and SD, respectively. *p ≤ 0.05, ***p ≤ 0.0005.

hGM-CSF antibody had signiﬁcantly reduced survival over a
period of seven days relative to untreated controls (Figure 2C).
Microscopic examination revealed inhibition of cell
differentiation in uninfected and infected monocytes treated
with a-hGM-CSF (Figure 2D). Similar results were also
observed when hGM-CSF receptor (CSF2RA) was blocked
through anti-CD116 antibody (Data not shown).
We next assessed whether exogenous hGM-CSF enhanced
monocyte survival during differentiation in the presence and
absence of M. tuberculosis infection. We added a range of hGMCSF doses (1-10 ng/5 million cells) to undifferentiated
monocytes isolated from three human subjects. Survival in
infected and uninfected controls was assessed in cells from the
same donor in the presence or absence of exogenous hGM-CSF.
hGM-CSF (2 ng/1 million cells) enhanced cell survival by over
30% by day 28 post-M. tuberculosis infection relative to
untreated infected macrophages (Figure 2E). Doses exceeding
2 ng hGM-CSF/1 million cells enhanced cell survival but also
induced cell proliferation and inhibited differentiation (data not
shown). Uninfected monocytes treated with 2 ng hGM-CSF/1
million monocytes survived signiﬁcantly longer relative to
untreated monocytes (Figure 2F). These data suggest that a
limited supplementation of GM-CSF could further extend the
survival of monocyte during M. tuberculosis infection.

M. tuberculosis (data not shown), and an increase in bacterial
burden was observed in these cells (Figure 1F). Furthermore,
viability of undifferentiated monocytes decreased rapidly relative
to differentiated macrophages over the seven-day infection period
(Figure 1G). These data suggest that undifferentiated monocytes
are more permissive for M. tuberculosis growth and infectioninduced cell death as compared to differentiated macrophages.

Host Macrophage Survival and
Intracellular M. tuberculosis Burden Is
Dependent on GM-CSF Signaling
To determine whether macrophage permissiveness for M.
tuberculosis growth and infection-induced cell death were
dependent on GM-CSF, we assessed M. tuberculosis
proliferation in healthy and infected macrophages in the
presence and absence of GM-CSF. We used an anti-human
GM-CSF antibody (a-hGM-CSF) to neutralize GM-CSF effect
on macrophages. We added a-hGM-CSF antibodies (2 mg/1
million cells) to monocytes before or after differentiation, as
earlier described. M. tuberculosis-infected undifferentiated
monocytes treated with a-hGM-CSF showed increased
bacterial burden and decreased survival over a period of seven
days relative to those treated with IgG isotype (Figures 2A, B).
Uninfected and undifferentiated monocytes treated with a-
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FIGURE 2 | GM-CSF-dependent control of bacterial burden, cell survival, and differentiation of human macrophages during M. tuberculosis infection. (A) M. tuberculosis
burden in a-hGM-CSF antibody-treated undifferentiated human macrophages versus IgG isotype-treated undifferentiated macrophages as measured through CFU assay over
seven days of infection. Concentration of a-hGM-CSF antibody/IgG isotype used for treatment was 2 mg/106 macrophages. (B) Cell viability of M. tuberculosis-infected and ahGM-CSF antibody-treated undifferentiated human macrophages versus IgG isotype-treated undifferentiated macrophages measured by alamarBlue assay over seven days
of infection. (C) Cell viability of a-hGM-CSF antibody-treated undifferentiated human macrophages versus IgG isotype-treated undifferentiated macrophages measured by
alamarBlue assay over seven days. (D) Morphology of a-hGM-CSF antibody-treated macrophages versus untreated macrophages with and without M. tuberculosis infection
at day 7 post-infection/treatment. Images were acquired at 20x magniﬁcation with an inverted brightﬁeld microscope using macrophages of a single random healthy donor. (E)
Cell viability of -infected and hGM-CSF-treated undifferentiated macrophages versus untreated undifferentiated macrophages measured by alamarBlue assay over seven days
of infection. (F) Cell viability of uninfected hGM-CSF-treated undifferentiated macrophages versus untreated undifferentiated macrophages measured by alamarBlue assay over
seven days of infection. Data represent average of three independent experiments carried out in duplicate. Bars and error bars represent means and SD, respectively.

(Figures 3B, C). With increasing exogenous hGM-CSF doses, a
time-dependent decrease in intracellular CFUs was observed,
indicating that GM-CSF may restrict M. tuberculosis by
promoting granulomatous response in cells (Figure 3C). Relative
to untreated cells, treatment with 2 ng of hGM-CSF/1 million
macrophages reduced bacterial burden by over 2.5 logs by day 28
post-infection. Notably, granuloma-like structures were also seen
early during infection (5-10 days) in untreated macrophages, and
though these cells could prevent intracellular proliferation of M.
tuberculosis bacilli, they could not reduce bacterial burden with time
(Figures 3A–C). We next examined if intrinsic levels of GM-CSF
produced by macrophages could prevent intracellular proliferation
of M. tuberculosis. The endocrine effect of GM-CSF in macrophages
was blocked using a-hGM-CSF, and intra-macrophage CFUs were

Exogenous hGM-CSF also increased the formation of
granulomatous structures in peripheral blood mononuclear cells
(PBMC)-derived monocytes (Figure 3A), a previously documented
phenomenon (21). While M. tuberculosis infection itself induced
granuloma-like structures in macrophage culture, exogenous hGMCSF further increased the size and number of granuloma-like
centers (Figure 3A). Conversely, treatment with a-hGM-CSF
reduced the granulomatous response in macrophages and
signiﬁcantly reduced the number and the size of granulomatous
structures. These granuloma-like structures were not seen in
uninfected macrophages (data not shown). Granuloma-like
structures began to disappear 14 days post-infection/exogenous
hGM-CSF treatment, but the number of M. tuberculosis CFUs
remained signiﬁcantly low relative to untreated macrophages
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FIGURE 3 | GM-CSF induces formation of granulomatous structures and differentiation of macrophages to control bacterial burden and host cell survival during M.
tuberculosis infection. (A) In vitro granuloma-like structure formation in untreated, hGM-CSF (2 ng/106macrophages), a-hGM-CSF (2 mg/106 macrophages) treated
macrophages. Macrophages were infected with M. tuberculosis (H37Rv; MOI 1:1) resulting in the formation of granulomas by day 7 post-infection. Images were
acquired at 4x magniﬁcation with an inverted brightﬁeld microscope using macrophages of a single random healthy donor. (B) At day 14 post-infection with M.
tuberculosis (rfpH37Rv; MOI 1:1), untreated cells show undifferentiated macrophage-like morphology, including rounder shape and shorter microvilli, whereas hGMCSF (2 ng/106 macrophages)-treated cells exhibit morphology similar to differentiated macrophages with ﬂat, elongated shape and longer dendrons. Images were
acquired at 40x magniﬁcation with an inverted ﬂuorescent/brightﬁeld microscope using macrophages of a single random healthy donor. More M. tuberculosis bacilli
(red) are visible in untreated cells relative to hGM-CSF-treated (2 ng/106 macrophages) cells. Images in A and B are representative images from twelve experiments
with 4X and 40X magniﬁcation, respectively. (C) Dose-dependent effect of hGM-CSF treatment on bacterial burden within macrophages up to 28 days post-M.
tuberculosis infection (H37Rv; MOI 1:1). (D) Effect of a-hGM-CSF antibody treatment on bacterial burden within macrophages up to 28 days post-M. tuberculosis
infection (H37Rv; MOI 1:1). Bacterial burden was not determined in a-hGM-CSF treated macrophages because of excessive cell death in this group after 14 days
post-infection. (E) Effect of a-hGM-CSF antibody treatment on cell viability of macrophages up to 28 days post-M. tuberculosis infection (H37Rv; MOI 1:1).
Treatment with hGM-CSF or a-GM-CSF antibody/IgG isotype (untreated control) was done every seven days starting from the day of infection. Data represent
average of three independent experiments carried out in duplicate. Bars and error bars represent means and SD, respectively.

examined up to 28 days post-infection (Figure 3D). A marked
increase in M. tuberculosis CFUs was observed in the ﬁrst 14 days
relative to untreated macrophages. After 21 days 100% cell death
was observed in a-hGM-CSF treated macrophages whereas
untreated macrophages maintained more than 50% viability at
this time point (Figure 3E). Taken together, these results clearly
indicated that self-survival of macrophages as well as their ability to
form granuloma and contain M. tuberculosis infection is dependent
on GM-CSF.

expression of cell death/survival related genes HSP27, BCL-xL, BCL2, BAX/BAK, and MCL1 and the mode of cell death during
exogenous hGM-CSF supplementation/antibody-mediated
depletion. M. tuberculosis-infected macrophages supplemented
with exogenous hGM-CSF (2 ng/1 million cells) showed
signiﬁcantly less apoptotic cell death over 14 days relative to
untreated macrophages (Figure 4A). Moreover, apoptotic cell
death was more common than necrotic cell death in infected
macrophages. GM-CSF supplementation resulted in signiﬁcantly
lower levels of apoptosis even in uninfected macrophages
(Supplementary Figure S3), indicating a homeostatic role for
GM-CSF in preventing apoptotic cell death. Anti-apoptotic gene
BCL-2 was upregulated ~2-fold in hGM-CSF-treated macrophages
in infected and uninfected groups at day 7 (Figure 4B). However,
BCL-xL, another anti-apoptotic gene, did not vary between groups.
Pro-apoptotic gene BAX was not signiﬁcantly up or downregulated
in hGM-CSF-treated macrophages relative to untreated controls.
Apoptosis as well as necrosis signiﬁcantly increased in infected and
uninfected macrophages treated with a-hGM-CSF antibodies, and

GM-CSF Mediated Cell-Survival and
Antimicrobial Effector Functions Are
Partly Autophagy-Dependent
The molecular mechanism through which GM-CSF may regulate
host cell survival and bacterial containment is unknown. We
investigated the downstream effects of GM-CSF supplementation/
depletion on cell death and survival pathways in uninfected and M.
tuberculosis-infected cells. Speciﬁcally, we assessed transcriptional
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FIGURE 4 | GM-CSF regulates apoptotic/necrotic cell death and bacterial control through autophagy-dependent and independent pathways. (A) Percentage and
proportion of apoptotic and necrotic cell death after 7 and 14 days post-M. tuberculosis infection in untreated and hGM-CSF(2 ng/106 macrophages)-treated
macrophages. At 7 and 14 days post-M. tuberculosis infection, hGM-CSF-treated and untreated macrophages were incubated with Apopxin solution and 7-ADD,
and ﬂuorescence [Ex/Em=490/525 nm (apoptosis, Ex/Em=550/650 nm (necrosis), Ex/Em=405/450 nm (healthy cells)] was measured by ﬂuorescence microscopy at
a magniﬁcation of 20X counting 25 ﬁelds per replicate for each condition. (B) Transcription level expression of cell survival cell death-associated genes BCL-2, BCLXL, and BAX in hGM-CSF (2 ng/106 macrophages)-treated and untreated macrophages with and without M. tuberculosis infection. Gene expression was measured
at seven days post-treatment/infection via qPCR assay. (C) Percentage and proportion of apoptotic and necrotic cell death in a-hGM-CSF antibody-treated and IgG
isotype-treated macrophages with and without M. tuberculosis infection at day 7. Fluorescent microscopy-based necrosis/apoptosis cell death assay kit was used to
determine the percentage of apoptotic and necrotic cell death as described for panel (A) Transcription level expression of cell survival associated genes BAX and
HSP27 in a-hGM-CSF antibody (2 mg/106 macrophages)-treated and untreated macrophages with and without M. tuberculosis infection was measured at seven
days post-treatment/infection via qPCR assay. (D) ROS and NO levels in a-hGM-CSF antibody-treated and untreated (IgG isotype-treated) macrophages at day 7
post-M. tuberculosis infection, as measured through DCFDA and DAF2-DA probes, respectively, using a ﬂuorimeter. Effect of nitric oxide synthase inhibitor L-NMMA
(2 mM/106 macrophages) on bacterial burden (E) and host cell viability (F) of M. tuberculosis-infected macrophages over seven days as measured through CFU and
alamarBlue assays, respectively. (G) Intracellular levels of antimicrobial peptide LL-37 in a-hGM-CSF -treated and untreated macrophages as measured via ELISA at
seven days post-infection. (H) Levels of LC3B puncta in a-hGM-CSF antibody-treated and untreated macrophages in the presence and absence of L-NMMA (2 mM/
106 macrophages) treatment at 7 days post-M. tuberculosis infection. LC3B positive puncta were detected through LC3B antibody staining using a ﬂuorescent
microscope. Effect of autophagy inducer (rapamycin) and autophagy inhibitor (3-MA) on bacterial burden (I) and host cell viability (J) of M. tuberculosis-infected
macrophages over seven days as measured by CFU and alamarBlue assays, respectively. Treatment with hGM-CSF or a-hGM-CSF antibody/IgG isotype was
performed every seven days beginning from the day of infection. Mtb, M. tuberculosis; pgs, picograms. Data represent average of three independent experiments
carried out in duplicate. Bars and error bars represent means and SD, respectively. *p ≤ 0.05, **p ≤ 0.005.

we observed a corresponding increase in pro-apoptotic BAX
expression (Figure 4C). Cell survival-associated gene HSP27 was
downregulated signiﬁcantly in M. tuberculosis-infected
macrophages treated with a−hGM-CSF antibody; uninfected
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macrophages showed a similar proﬁle with comparatively lower
magnitude of difference.
Together, these data indicated a pattern of apoptosis and
necrosis inhibition in macrophages with higher GM-CSF levels
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that were most prominent in infected macrophages. To
determine whether this GM-CSF effect was mediated by
apoptosis inhibition or other antimicrobial host defense
pathways, we assessed antimicrobial effector mechanisms,
including reactive oxygen species (ROS)/nitric oxide (NO)
generation, antimicrobial peptide production, autophagic ﬂux
in GM-CSF-competent and GM-CSF-depleted macrophages
during M. tuberculosis infection. GM-CSF-competent
macrophages did not show any signiﬁcant differences in ROS
production levels compared to GM-CSF-depleted macrophages
(Figure 4D). NO levels in GM-CSF-competent macrophages
were signiﬁcantly higher compared to GM-CSF-depleted
macrophages, indicating that NO may be an antimicrobial
effector mechanism induced by GM-CSF signaling. To
determine if an NO-mediated effector mechanism was
associated with macrophage survival, we measured host and
bacterial cell survival in GM-CSF-competent and GM-CSFdepleted macrophages treated with a pharmacological inhibitor
of NO; NG-Methyl-L-arginine acetate salt (L-NMMA)
(Figures 4E, F). In GM-CSF-competent macrophages, LNMMA treatment resulted in increased bacterial burden but
not signiﬁcant cell death. In GM-CSF-depleted macrophages,
untreated and L-NMMA-treated cells showed increased bacterial
burden and host cell death. These data suggest that NO
contributes to GM-CSF-mediated antimicrobial effector
mechanisms but not host cell survival.
Since NO is known to induce production of antimicrobial
peptides and activate autophagy, which could also contribute to
boosting intracellular host defenses, antimicrobial peptide
cathilicidin (LL-37) and autophagic ﬂux in GM-CSF competent
and depleted macrophages were further examined. LL-37 levels
were similar between GM-CSF-competent and GM-CSF-depleted
macrophages, indicating that GM-CSF-mediated restriction of M.
tuberculosis bacilli in macrophages is not dependent on LL-37
(Figure 4G). Strikingly, increased autophagy ﬂux (as examined
through the LC3B positive puncta) in GM-CSF competent
macrophages was observed as compared to GM-CSF depleted
macrophages (Figure 4H). Increased LC3 B gene expression at the
transcription level was also observed in hGM-CSF-treated infected
and uninfected macrophages relative to untreated macrophages
(Supplementary Figure S4). Interestingly, blockade of NO via LNMMA did not affect autophagic ﬂux in GM-CSF competent/
depleted macrophages, indicating that GM-CSF-mediated
induction of autophagy is NO-independent (Figure 4H). To
determine whether GM-CSF-mediated autophagy affects host
and bacterial cell survival, we induced and blocked autophagy
using rapamycin and 3-MA, respectively, in GM-CSF-competent
macrophages during M. tuberculosis infection. Low-dose
rapamycin resulted in decreased bacterial burden, but higher
doses reversed this effect. Blockade of autophagy through 3-MA
resulted in increased bacterial burden and decreased cell survival
(Figures 4I, J). Thus, GM-CSF-dependent host cell survival and
antimicrobial effector mechanisms may be partially autophagydependent; however, the data also indicated that precise regulation
of autophagy may be equally important for pathogen restriction
and host cell survival.
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GM-CSF Mediates Regulatory Immune
Responses in Macrophages and Increases
Antigen Presentation to T Cells During
M. tuberculosis Infection
We evaluated a panel of pro- and anti-inﬂammatory cytokines in
GM-CSF-competent/deﬁcient macrophages three days post-M.
tuberculosis infection (Figure 5A). GM-CSF-depleted
macrophages secreted signiﬁcantly lower levels of IL-1b, IL-12,
and IL-10 and signiﬁcantly higher levels of TNF-a and IL-6
compared to GM-CSF-competent macrophages. No signiﬁcant
difference was observed in IL-4 and IL-13 levels. Thus, GM-CSF
signaling may simultaneously be inducing pro-and antiinﬂammatory immune responses and a dual GM-CSF response
may be considered more of a regulatory immune response than a
pro-inﬂammatory response. Interestingly, IL-12 levels from GMCSF-competent macrophages were high relative to GM-CSFdeﬁcient macrophages, suggesting that GM-CSF may induce
macrophage maturation (22).
We next evaluated whether GM-CSF-competent/deﬁcient
macrophages had different T cell priming capabilities during
M. tuberculosis infection. We used an in vitro antigen
presentation assay using a CD4 hybridoma T cell recognizing a
speciﬁc epitope on Ag85B to assess T cell priming by GM-CSFcompetent/deﬁcient macrophages. IL-2 levels secreted from
hybridoma T cells were monitored over time with overlay to
M. tuberculosis-infected macrophages (Figure 5B). GM-CSFcompetent macrophages induced higher levels of antigen
presentation after two days of infection, though the difference
was not signiﬁcant relative to GM-CSF-depleted macrophages.
However, GM-CSF competent macrophages were able to sustain
a much higher levels of antigen presentation beyond day 3 post
infection as compared to GM-CSF deﬁcient macrophages, hence
further suggesting the critical role of GM-CSF signaling in
sustenance of antigen presentation and efﬁcient processing and
presentation of antigens to CD4T cells. it is also possible that low
number of viable cells in GM-CSF deﬁcient macrophages could
have also contributed to the reduction in overall levels of antigen
presentation. However, the magnitude of difference in IL-2 levels
secreted by untreated vs anti-GM-CSF antibody treated
macrophages is much higher at day 7 post infection (almost 10
fold: 30 picograms vs 300 picograms) (Figure 5B) as compared
to the magnitude of difference in cell viability of untreated vs
anti-GM-CSF antibody treated macrophages (less than 2 fold)
(Figure 3E) at day 7 post infection. We thus believe that during
the late phase of infection, GM-CSF is affecting the antigen
presentation capability of macrophages.
We further compared phagosome maturation events in GMCSF-competent/deﬁcient macrophages after M. tuberculosis
infection. At three days post-infection, over 50% of M.
tuberculosis-containing phagosomes colocalized with LC3B
positive endosomes in GM-CSF-competent macrophages, with
GM-CSF deﬁcient macrophages exhibiting less than 20% colocalization (Figure 5C). Notably, this difference was not
signiﬁcant during the ﬁrst 24 h of infection (data not shown).
Thus, increased fusion of LC3B containing endosomes with M.
tuberculosis bacilli indicated an autophagy dependent maturation
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FIGURE 5 | Effect of a-hGM-CSF antibody on pro- and anti-inﬂammatory cytokine secretion, antigen presentation, and phagosome maturation of macrophages. (A)
Secreted levels of pro- and anti-inﬂammatory cytokines by GM-CSF-competent (control) and GM-CSF-depleted (a-hGM-CSF antibody-treated) macrophages at three days
post-infection with M. tuberculosis. MOI = 1; a-hGM-CSF antibody = 2 mg/106 macrophages. (B) Secreted levels of IL-2 by M. tuberculosis Ag85B-speciﬁc T cells during
co-culture with GM-CSF competent (control) and GM-CSF depleted (a-GM-CSF antibody-treated) macrophages at different times post-infection. (C) Localization of M.
tuberculosis (red) phagosomes and LC3B+ autophagosomes (green) within GM-CSF competent (control) and GM-CSF depleted (a-GM-CSF antibody-treated) macrophages
after seven days of infection. Phagosomes were labeled using RFP M. tuberculosis and autophagosomes were labeled with LC3B-speciﬁc antibodies. Images were acquired
at 60x magniﬁcation with an inverted ﬂuorescent microscope using macrophages of a single random healthy donor and were analyzed using confocal microscopy and NIKON
NIS element software. Bar graph shows the quantitation of percent co-localization of M. tuberculosis and autophagosomes in macrophages representing an average of three
replicates, each including 25 ﬁelds. (D) Western blot proﬁle of Atg5, Atg7, and b- actin expression by macrophages treated with hGM-CSF/a-hGM-CSF antibody relative to
untreated macrophages three days with and without M. tuberculosis infection (three days post-infection). M, macrophages; Mtb, M. tuberculosis; pg, picograms. Data are
representative of three independent experiments carried out in duplicate. Bars and error bars represent means and SD, respectively. *p ≤ 0.05, **p ≤ 0.005, ***p ≤ 0.0005.

from individuals with active TB to healthy controls. Monocytes
from healthy controls and newly diagnosed TB patients were
isolated and compared for their ability to produce GM-CSF,
control host cell survival, and restrict M. tuberculosis growth. M.
tuberculosis infection increased macrophage GM-CSF
production in both populations after seven days of infection
(Figure 6A), though macrophages from active TB patients (n=4)
produced signiﬁcantly less than those from healthy controls
(n=5). These levels remained low throughout the 14-day
infection period (Supplementary Figure S5) and translated to
increased bacterial burden and host cell death relative to healthy
controls (Figures 6B, C).
Because some of our active TB population also had preexisting
diabetic conditions, which can cause a metabolic reprogramming of
immune cells that leads to defective immune response against TB,
we examined whether diabetes-induced metabolic changes were
associated with macrophage GM-CSF production. We ﬁrst
characterized the central metabolic state of macrophages from
active TB patients and healthy controls by examining the

of phagosomes. Autophagosome-associated LC3B and other
autophagy-related genes, including LC3B, Atg5 and Atg7, also
demonstrated increased expression at the transcription/
translational level in hGM-CSF-treated macrophages and
decreased expression in a-GM-CSF-treated macrophages
(Figures 5C, D), further indicating the role of GM-CSF in
macrophage autophagy regulation. Thus, increased maturation
of M. tuberculosis-containing phagosomes via GM-CSF-mediated
autophagy may degrade M. tuberculosis bacilli and process its
antigens, resulting in improved and sustained antigen presentation
in macrophages.

Macrophages From Active TB Patients
Produce Lower Levels of GM-CSF and
Exhibit a Distinct Metabolic State
As our results indicated that natural variations in GM-CSF
production/signaling could be a factor in determining an
individual’s vulnerability to TB, we conducted parallel studies
to compare patterns of GM-CSF production in macrophages
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FIGURE 6 | Different levels of GM-CSF production in macrophages of active TB patients and healthy controls and its association with intracellular bacterial control, survival
of the host cells, and metabolic state. (A) Secreted levels of GM-CSF by macrophages of active TB patients versus healthy controls post-differentiation and M. tuberculosis
infection. GM-CSF levels were measured at day seven post-infection. (B) M. tuberculosis burden in macrophages of active TB patients versus healthy controls postdifferentiation measured by CFU assay at seven days after infection. (C) Percentage and proportion of apoptotic and necrotic cell death in M. tuberculosis-infected
macrophages of active TB patients versus healthy controls at seven days post-infection measured by ﬂuorescent microscopy-based apoptotic/necrotic assay. (D) Relative
fold change in RNA concentration of speciﬁc genes (GLUT1, GLUT6, HK2, HK3, LDHA, and PPAR-g) in PBMC-derived macrophages of active TB patients versus healthy
subjects as determined by qPCR. Student’s t-test was used for means comparison between active TB patients versus healthy subjects. (E) Secreted levels of GM-CSF by
M versus MME macrophages at different times post-M. tuberculosis infection. GM-CSF levels were measured in macrophage (5x106) culture supernatants using sandwich
ELISA. (F) Cell viability of M. tuberculosis-infected M versus MME macrophages measured by alamarBlue assay over seven days of infection. (G) Relative fold change in
RNA concentration of speciﬁc genes (PGLK, MCT4, LDHA, HK3, and PPAR-g) in PBMC-derived macrophages of active TB patients versus healthy subjects as determined
by qPCR. Student’s t-test was used for means comparison between M versus MME macrophages. (H) M. tuberculosis burden in M versus MME macrophages as
measured through CFU assay over seven days of infection. Mtb, M. tuberculosis; pgs, picograms. Data represent the average of three independent experiments carried out
in duplicate. Bars and error bars represent means and SD, respectively. *p ≤ 0.05, **p ≤ 0.005, ***p ≤ 0.0005.

PPAR-g in MME macrophages relative to control macrophages
(Figure 6G). MME macrophages also showed a signiﬁcantly
higher intracellular M. tuberculosis burden relative to untreated
macrophages (Figure 6H). Thus, metabolic dysregulation may
also cause a reduction in macrophage GM-CSF production that
results in their reduced survival and increased permissiveness to
M. tuberculosis growth.

expression of genes related to glycolysis and oxidative
phosphorylation. Macrophages from active TB patients exhibited
signiﬁcant downregulation (1.5- 20 fold) of genes encoding glucose
transporters 1 and 6 (GLUT1 and 6), glycolytic enzymes/isozymes
hexokinases (HK2 and HK3), phosphofructokinase 1 (PFK1), and
lactate dehydrogenase A (LDHA) relative to healthy controls
(Figure 6D). Further, decreased glycolytic ﬂux also resulted in
concurrent downregulation of lipid metabolism-related gene
Peroxisome Proliferator-Activated Receptor Gamma (PPAR-g) in
macrophages from active TB patients relative to controls.
We next evaluated whether metabolic dysregulation was
causing reduced GM-CSF production in macrophages. We
induced metabolic dysregulation in macrophages by treating
cells with glucose, insulin, and palmitate (23) and quantiﬁed
GM-CSF production in these metabolically dysregulated
macrophages (MME macrophages) relative to a control group
of untreated cells from the same donor. MME macrophages
produced signiﬁcantly reduced levels of GM-CSF, and exhibited
signiﬁcantly reduced survival following M. tuberculosis infection
relative to untreated control macrophages (Figures 6E, F). We
also observed reduced expression of glycolysis-related genes
Protein glycosylation K (PGLK), Monocarboxylate transporter
4 (MCT4), LDHA, and HK3, and lipid metabolism-related gene
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DISCUSSION
In humans, the development of adaptive immunity against M.
tuberculosis infection takes 2-3 weeks after ﬁrst exposure (24).
However, symptomatic disease does not appear in 90% of M.
tuberculosis-infected individuals during this early stage when
mostly innate immune cells are participating in the immune
response. This indicates initial clearance or containment of
infection by the innate immune system, and highlights the
importance of innate immunity in controlling M. tuberculosis
infection. Macrophages are both the primary host cells for M.
tuberculosis and the ﬁrst line of innate cellular defense (25).
Macrophage populations that interact with M. tuberculosis have
exhibited tremendous heterogeneity and plasticity, with diverse
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Interestingly, when monocytes were infected with M.
tuberculosis prior to their differentiation, increased intracellular
growth of the pathogen was observed as well as accelerated death
of host cells (Figures 1F, G). At the same time, these infected
undifferentiated monocytes were also unable to produce GM-CSF,
indicating that M. tuberculosis can interfere with monocytes’
natural ability to produce GM-CSF and differentiation into
macrophages. In contrast, GM-CSF production was increased in
differentiated macrophages after M. tuberculosis infection
(Figure 1A). This up-regulation of GM-CSF by M. tuberculosis
has been shown to be mediated by the PI3-K/MEK1/p38 MAPKassociated signaling pathway (33). However, it is unclear how this
phenomenon is reversed in undifferentiated macrophages. There
is considerable evidence of increased permissiveness of
undifferentiated monocytes to M. tuberculosis growth. Chronic
inﬂammatory response is known to drive this phenomenon that
eventually results in increased host cell death (34). An increased
bacterial burden and associated cell death of undifferentiated
monocytes post-M. tuberculosis infection (Figures 1F, G)
corroborated these earlier ﬁndings and further indicated that cell
death triggered by M. tuberculosis could have caused the reduction
in secreted GM-CSF levels by undifferentiated monocytes.
While increased infection-induced cell death was observed in
undifferentiated monocytes, differentiated macrophages were able
to prevent cell death after M. tuberculosis infection (Figures 2B, C,
E, F). Human TB granulomas are also known to express GM-CSF
(35). The protective effect of this cytokine against TB in mediating
granulomatous response and restriction of the pathogen within
macrophages has been shown previously (16, 36). We sought to
determine the mechanism through which GM-CSF could have
prevented infection-induced cell death. Anti-apoptotic genes, as
well as self-renewal genes such as BCL-2, were upregulated in GMCSF-competent macrophages (Figure 4B). GM-CSF is a known
mitogenic signal for the local proliferation and self-renewal of
macrophages which indicates that GM-CSF may increase the
survival of the host cells by enhancing activation of cell
proliferation genes. Indeed, local proliferation of macrophages
has been described in the granulomatous lesions formed during
experimental Goodpasture’s syndrome (37, 38), similar to the
granulomatous response and proliferative behavior we observed in
GM-CSF-competent macrophages (Figure 3A). Morover,
enhanced cell proliferation of macrophages during granuloma
formation is also known to reduce apoptosis (39). Thus, GMCSF-mediated self-renewal/survival, local proliferation of
macrophages in the lungs, and increased formation of protective
granulomatous structures during TB accentuate the importance of
granuloma targeting therapies for TB.
Intracellular host defense mechanisms triggered by GM-CSF are
poorly understood. We used a-hGM-CSF antibody to identify the
involvement of these antimicrobial effector mechanisms (Figures 4E,
F, H). We demonstrated that GM-CSF-mediated regulation of
autophagy was not only critical in controlling the bacterial burden
within macrophages, but also in preventing cell death (Figures 4I, J).
While excessive exogenous supplementation of GM-CSF resulted in
macrophage cell death, controlled supplementation of this cytokine
enhanced macrophage cell survival as well as bacterial killing

functional phenotypes. The local microenvironment in which M.
tuberculosis interacts with macrophages has been suggested to
inﬂuence the phenotype of macrophages and the outcome of
infection (26, 27). However, the secreted soluble mediators and/
or other immune components that constitute the
microenvironment of macrophages during M. tuberculosis
infection are not understood well.
GM-CSF is one of the cytokines that may polarize macrophages
toward the protective phenotype and has been increasingly
recognized as an essential factor for TB resistance (13, 28, 29). A
recent study showed that GM-CSF is produced upon infection with
M. tuberculosis and that human macrophages’ antimycobacterial
properties correlated with their ability to produce GM-CSF (14). In
a mouse model of TB, we and others have previously shown the
GM-CSF expression in lung epithelial cells and the hematopoietic
compartment (16, 30, 31). More recent investigations have shown
that conventional and non-conventional T cells (iNK and gd T cells)
also produce GM-CSF, which was critical for host protection during
experimental TB in mice (32). However, a key observation often
overlooked is that the manifestation of TB pathogenesis and overall
outcome of infection in humans is different than in mice, which are
naturally susceptible to TB. Therefore, it is imperative to examine
whether differential GM-CSF production and its association with
TB susceptibility/resistance exists in the human population.
The study presented here focused only on macrophageproduced GM-CSF and suggests GM-CSF’s critical role in
controlling infection and preventing cell death of macrophages
(Figures 1, 2). However, it does not rule out the possible
contribution of other myeloid and non-myeloid cell-produced
GM-CSF in protective immunity against TB. One study in a
mouse model of TB found that conventional T cell- (CD4 and
CD8) produced GM-CSF was also protective and required for
control of M. tuberculosis infection, though only when GM-CSF
is not produced by other cell types (32). In the current study, the
human macrophages that were able to produce competent levels
of GM-CSF contained the M. tuberculosis infection (Figure 1C)
even in the absence of T cells, indicating that T cell-produced
GM-CSF may not be essential in humans if macrophages can
produce the required quantity of GM-CSF. Nonetheless, it is
possible that T cell-produced GM-CSF could be important when
macrophages or other cells are not producing enough.
Contribution of non-conventional/conventional T cellproduced GM-CSF in controlling TB in a mouse model of TB
could also be due to sub-optimal production of this cytokine by
their macrophages. Indeed, a recent study conﬁrmed that mouse
macrophages produced signiﬁcantly less GM-CSF compared to
human macrophages after infection with M. tuberculosis (17);
this directly correlated with their reduced life span and ability to
control M. tuberculosis infection. In our study, differentiated
macrophages in the majority of our human samples were able to
control M. tuberculosis growth and survive for an extended
period, as seen in the majority of humans who do not develop
active TB disease after exposure (Figure 1).
The number of M. tuberculosis bacilli in differentiated
macrophages in most individuals in our study remained
restricted and decreased over a period of time (Figure 1B).
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(Figures 2E, F, and 3C). These data indicate the critical role of a
precisely regulated autophagic process in protecting against M.
tuberculosis infection, which has been previously documented (40).
GM-CSF-competent macrophages also exhibited lower levels of
inﬂammatory cytokines and higher levels of autophagic ﬂux as
compared to GM-CSF-deﬁcient macrophages (Figure 5),
suggesting the possible role of GM-CSF-mediated autophagy in the
reduction of inﬂammation during M. tuberculosis infection (41).
Along this line, further research deﬁning the mechanistic basis of
anti-inﬂammatory as well as anti-apoptotic effect of autophagic
cellular processes during M. tuberculosis infection are warranted to
fully realize the potential of GM-CSF targeted host directed therapies.
Remarkably, simultaneous production of pro- and antiinﬂammatory cytokines by GM-CSF-competent macrophages
restricted intracellular M. tuberculosis infection (Figure 5A) which
further highlights the importance of a balanced immune response to
effectively control infection without causing damage. For instance,
GM-CSF-competent macrophages produced signiﬁcantly more IL12 but less TNF-a compared with GM-CSF-deﬁcient macrophages
(Figure 5A), even though both of these cytokines are proinﬂammatory. TNF-a is a known mediator of tissue damage
during TB (42). Thus, downregulation of TNF-a could be useful in
reducing the cellular damage caused by TB. IL-12 mediates early T
cell activation without causing excessive inﬂammation during M.
tuberculosis infection (43). IL-12 also induces maturation of
macrophages and dendritic cells, which is critical for effective
antigen presentation to activate antigen speciﬁc T cells during M.
tuberculosis infection (44, 45). Improved antigen presentation was
indeed evident in GM-CSF-competent macrophages that produced
higher levels of IL-12 (Figures 5A, B). This IL-12-mediated induction
of antigen presentation in antigen presenting cells (APCs) could help
in generating optimal interferon-g (IFN-g) response by T cells, which
can further contribute to the restriction of M. tuberculosis growth in
macrophages/dendritic cells. Nonetheless, the mechanism through
which GM-CSF promotes antigen presentation along with the
cellular processes that manifest the dual control of both
inﬂammatory as well as anti-inﬂammatory cytokines in APCs
needs to be fully understood to ascertain the therapeutic potential
of GM-CSF against TB.
GM-CSF-mediated control of immune response in
macrophages also appears interconnected with the regulation of
cellular metabolism. M. tuberculosis is known to remodel the
metabolism of immune cells and it has been proposed that the
net outcome to M. tuberculosis infection clearance or chronic
disease is likely dependent on the combined immunologic and
metabolic status of the immune cells that participate in the infection
process (46). GM-CSF-competent macrophages did not allow
skewing of bioenergetics toward the glycolysis and pentose
phosphate pathway after M. tuberculosis infection (Figure 6D).
Thus, GM-CSF could play a key role in resisting the metabolic
changes induced by M. tuberculosis infection and maintain a
homeostatic metabolic status in phagocytes. Resistance to the
metabolic reprogramming of macrophages during M. tuberculosis
infection can protect their effector functions and antimicrobial
response, which can ultimately govern the outcome of M.
tuberculosis-host interactions. Active TB patient macrophages
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with decreased GM-CSF production displayed increased
susceptibility to M. tuberculosis, further highlighting the link
between dysregulation of cellular metabolism and GM-CSF
(Figures 6A–D). While macrophages of active TB patients who
had preexisting DM produced less GM-CSF compared to healthy
controls, our data indicate that metabolic dysregulation is likely
responsible for the reduced level of GM-CSF (Figures 6E–G).
However, more work is needed to elucidate the intricate
relationship between metabolic programming pathways and GMCSF signaling.
A comprehensive understanding of the immune-metabolic
processes occurring in host cells during M. tuberculosis infection,
and the host/bacterial components that mediate their regulation
will drive novel treatment/vaccination strategies to control TB more
effectively. With future studies, the GM-CSF signaling pathway that
regulates innate immune responses and cellular metabolism could
be harnessed for host-directed therapeutic strategies to promote
bacterial clearance and improve treatment outcomes.
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